SCHEDULE 13G/A: Deerfield Entities Maintain 7.16% Passive Stake in Indivior PLC
Beneficial Ownership Disclosure
Deerfield Mgmt, L.P., Deerfield Management Company, L.P., Deerfield Partners, L.P., and James E. Flynn have collectively reported a continued 7.16% beneficial ownership in Indivior PLC as of December 31, 2024, held for passive investment purposes.
Summary
- The filing is an Amendment No. 1 to a Schedule 13G, disclosing beneficial ownership of Ordinary Shares of Indivior PLC.
- The reporting persons are Deerfield Mgmt, L.P., Deerfield Management Company, L.P., Deerfield Partners, L.P., and James E. Flynn.
- As of December 31, 2024, the aggregate amount beneficially owned by each reporting person is 8,883,160 Ordinary Shares.
- This represents 7.16% of the class of Indivior PLC's Ordinary Shares.
- All reporting persons share both voting and dispositive power over the 8,883,160 shares.
- The shares are held for passive investment purposes and not with the intent to change or influence the control of the issuer.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing disclosing beneficial ownership and does not contain information that would significantly alter the company's fundamental outlook or operations. It is neutral in sentiment.
Positives
- The disclosure provides transparency regarding a significant institutional investor's continued stake in Indivior PLC.
- The investment is stated to be for passive purposes, indicating no immediate intent to influence company control or operations.
Future Outlook
The document does not contain any forward-looking statements or guidance regarding Indivior PLC's future performance or strategic direction, as it is a beneficial ownership disclosure.
Industry Context
This filing is a routine disclosure by a healthcare-focused investment firm, Deerfield Management, regarding its passive stake in Indivior PLC, a pharmaceutical company. It reflects a standard investment position within the healthcare sector, without indicating any specific industry trends or competitive actions.
Stakeholder Impact
- Shareholders: Provides transparency regarding the composition of the company's significant shareholders, confirming a substantial passive investment by Deerfield entities.
Key Dates
| Date | Description |
|---|---|
| 12/31/2024 | Date of event which requires the filing of this statement (beneficial ownership snapshot date). |
| 02/13/2025 | Date the Schedule 13G/A was signed and filed. |
Keywords
Indivior PLC, Deerfield Mgmt, Deerfield Management Company, Deerfield Partners, James E. Flynn, Schedule 13G, beneficial ownership, passive investment, pharmaceuticals, healthcare investment
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.